Experienced in Acute Intermittent Porphyria

Francois D'heygere

Kortrijk, VLG, BE 
Experienced in Acute Intermittent Porphyria
Kortrijk, VLG, BE 
OverviewLocationsClinical Research

Overview

Francois D'heygere practices in Kortrijk, Belgium. Mr. D'heygere is rated as an Experienced expert by MediFind in the treatment of Acute Intermittent Porphyria. His top areas of expertise are Acute Intermittent Porphyria, Colitis, Viral Gastroenteritis, and Hemorrhagic Proctocolitis.

His clinical research consists of co-authoring 25 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Acute Intermittent Porphyria.

Gender
Male

Locations

Kortrijk, VLG, Belgium
Other Locations
Yvoir, WAL, Belgium
AZ Sint Lucas
Brugge, VLG, Belgium
AZ Delta
Roeselare, VLG, Belgium
AZ Imelda
Bonheiden, VLG, Belgium
Ziekenhuis Oost Limburg
Genk, VLG, Belgium
Leuven, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Prospective Study to Assess the Efficacy of Switching to Infliximab in Moderately to Severely Active Chrohn's Disease Patients With Primary Non-response or Loss of Response to Adalimumab
Prospective Study to Assess the Efficacy of Switching to Infliximab in Moderately to Severely Active Chrohn's Disease Patients With Primary Non-response or Loss of Response to Adalimumab
Enrollment Status: Completed
Publish Date: January 05, 2023
Intervention Type: Drug

25 Total Publications

Real-world Effectiveness and Safety of Tofacitinib in Multi-Refractory Ulcerative Colitis: insights from a Belgian Cohort with prior Anti-TNF and Vedolizumab Exposure.
Real-world Effectiveness and Safety of Tofacitinib in Multi-Refractory Ulcerative Colitis: insights from a Belgian Cohort with prior Anti-TNF and Vedolizumab Exposure.
Journal: Acta gastro-enterologica Belgica
Published: October 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. D'heygere's expertise for a condition
ConditionClose
        View All 10 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile